Duloxetine for Multiple Sclerosis Pain

Clinical trial NCT00755807 · COMPLETED

Trial details

NCT number: NCT00755807
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2008-10-01
Primary completion: 2010-08-01
Enrollment: 239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.